The 7th Annual World CDx Boston Summit 2016 offers end to end content dedicated to help you rapidly progress from exploratory biomarker to registrational CDx, align clinical co-development and ensure reimbursement and market access success for your precision therapies and assays.
With the rise of liquid biopsies, NGS and other multi-omic technologies, overcome disease heterogeneity and validate exploratory biomarkers to accurately stratify your therapy and future CDx:
Understand the cost/benefit analysis to decide when and how to embark on a full CDx strategy. Overcome trial design, patient recruitment and data challenges to ensure rapid and aligned clinical co-development:
Navigate constantly evolving regulatory guidelines and prepare for market access, reimbursement & health economics challenges on a global scale. Ensure you have done your due diligence with your partners to achieve maximum value.
In detail, uncover the key topics and industry shaping discussion taking place at World CDx Boston here.
Through senior level networking and unrivalled learning, define your most efficient CDx roadmap. Improve your discovery, development and commercialization of biomarker-based precision therapies & assays.
“World CDx was a fantastic event both in terms of the science and the networking opportunities."
- Oscar Puig, Biomarker Leader, Oncology, Roche